Plunkett Research Online: Ipsen SA

IPSEN SA (IPSEY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ipsen SA is a France-based biopharmaceutical company that produces drugs for oncology, neurosciences and rare diseases. The firm also has a consumer healthcare business. In relation to oncology, Ipsen is engaged in providing biopharmaceutical solutions for prostate, neuroendocrine tumors, bladder,.....



Ipsen SA
Ticker: IPSEY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 0158335000
Fax: 33 0158335001
Address: 65 quai Georges Gorse
Billancourt Cedex
Boulogne, 92650 France

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

David MeekCEO
Stephane BessetteExec. VP-Human Resources
See More
Ipsen SA is a France-based biopharmaceutical company that produces drugs for oncology, neurosciences and rare diseases. The firm also has a consumer healthcare business. In relation to oncology, Ipsen is engaged in providing biopharmaceutical solutions for prostate, neuroendocrine tumors, bladder,.....See More See More

Auditor: Deloitte & Associes
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Cabometyx
Somatuline
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: